Literature DB >> 26289088

Clinicopathological characteristics of patients with immunoglobulin A nephropathy showing acute exacerbations after favorable long-term clinical courses.

Mai Tanaka1, Yoichi Miyazaki2, Kentaro Koike1, Hiroyuki Ueda1, Nobuo Tsuboi1, Keita Hirano1, Hideo Okonogi1, Makoto Ogura1, Tetsuya Kawamura1, Takashi Yokoo1.   

Abstract

BACKGROUND: Sometimes, acute and progressive proteinuria increases occur in patients with IgA nephropathy (IgAN) after favorable long-term clinical courses of >10 years, but their clinical and histological characteristics are not well understood.
METHODS: We retrospectively selected 20 IgAN patients who had been followed for >10 years after their initial biopsies ((1st)Bx) and underwent second biopsies ((2nd)Bx), because their proteinuria increased to >1 g/day. Eight patients with acute exacerbations (Group A) showed acute proteinuria increases after long periods of mild proteinuria. Their clinicopathological characteristics were analyzed as a case series and were compared with those in Group B that comprised 12 patients with persistent proteinuria.
RESULTS: Group A experienced acute proteinuria increases and significant hematuria increases compared with the -1-year (P = 0.006) and -3-year (P = 0.010) time points before the (2nd)Bx, which contrasted to the clinical course in Group B. In Group A, glomerulosclerosis (GS) and the arteriosclerosis score did not differ between the (2nd)Bx and the (1st)Bx, and most patients (88 %) showed cellular and/or fibrocellular crescents within the (2nd)Bx. Compared with Group B, the (2nd)Bx revealed that the percentage of cellular and/or fibrocellular crescents (P = 0.001) was significantly higher, whereas the percentage of GS (P = 0.012) and the arteriosclerosis score (P = 0.020) were significantly lower in Group A.
CONCLUSION: Rapid proteinuria and hematuria increases, and acute histological lesions characterize acute exacerbations in IgAN after favorable long-term clinical courses.

Entities:  

Keywords:  Crescents; IgA nephropathy; Prognosis; Recurrence

Mesh:

Year:  2015        PMID: 26289088     DOI: 10.1007/s10157-015-1153-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  25 in total

1.  Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.

Authors:  O Hotta; M Miyazaki; T Furuta; S Tomioka; S Chiba; I Horigome; K Abe; Y Taguma
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

Review 2.  Hyperfiltration and glomerulosclerosis.

Authors:  Thomas H Hostetter
Journal:  Semin Nephrol       Date:  2003-03       Impact factor: 5.299

3.  Low glomerular density with glomerulomegaly in obesity-related glomerulopathy.

Authors:  Nobuo Tsuboi; Yasunori Utsunomiya; Go Kanzaki; Kentaro Koike; Masahiro Ikegami; Tetsuya Kawamura; Tatsuo Hosoya
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

4.  Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria.

Authors:  Takehiko Kawaguchi; Norio Ieiri; Shin Yamazaki; Yasuaki Hayashino; Brenda Gillespie; Mariko Miyazaki; Yoshio Taguma; Shunichi Fukuhara; Osamu Hotta
Journal:  Nephrology (Carlton)       Date:  2010-02       Impact factor: 2.506

5.  IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.

Authors:  L Frimat; S Briançon; D Hestin; B Aymard; E Renoult; T C Huu; M Kessler
Journal:  Nephrol Dial Transplant       Date:  1997-12       Impact factor: 5.992

6.  Clinical remission and pathological progression after tonsillectomy in a renal transplant patient with recurrent IgA nephropathy.

Authors:  Ken Sakai; Manabu Saneshige; Jirou Takasu; Taketo Yanagisawa; Yujirou Aoki; Takeshi Kawamura; Sonoo Mizuiri; Atsushi Aikawa
Journal:  Clin Transplant       Date:  2009-08       Impact factor: 2.863

7.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Authors:  Ian S D Roberts; H Terence Cook; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Daniel C Cattran; Rosanna Coppo; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; John Feehally; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

8.  Remission of proteinuria improves prognosis in IgA nephropathy.

Authors:  Heather N Reich; Stéphan Troyanov; James W Scholey; Daniel C Cattran
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

9.  Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients.

Authors:  Peicheng Shen; Liqun He; Yi Li; Yunman Wang; May Chan
Journal:  Nephron Clin Pract       Date:  2007-06-26

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  1 in total

1.  Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.

Authors:  Akira Mima
Journal:  Rheumatol Int       Date:  2017-03-02       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.